SYNTHETIC METHODS PERTAINING TO TERT-BUTYL-BENZENE-BASED COMPOUNDS
    3.
    发明申请
    SYNTHETIC METHODS PERTAINING TO TERT-BUTYL-BENZENE-BASED COMPOUNDS 审中-公开
    对叔丁基苯基化合物的合成方法

    公开(公告)号:US20130190525A1

    公开(公告)日:2013-07-25

    申请号:US13748046

    申请日:2013-01-23

    CPC classification number: C07C41/01 C07C41/16 C07C67/08 C07C43/164 C07C69/76

    Abstract: According to some aspects, the present disclosure pertains to methods of forming dimethyl 5-tert-butylisophthalate which comprise comprising converting 5-tert-butylisophthalic acid into dimethyl 5-tert-butylisophthalate in synthesis procedures that comprises methanol and a dehydrating agent as chemical reagents. In other aspects, the present disclosure pertains to methods of forming 5-tert-butyl-1,3-bis(1-methoxy-1-methylethyl)benzene that comprise deprotonating 5-tert-butyl-1,3-bis(1-hydroxy-1-methylethyl)benzene with a Brønsted-Lowry superbase and methylating the deprotonated 5-tert-butyl-1,3-bis(1-hydroxy-1-methylethyl)benzene to form the 5-tert-butyl-1,3-bis(1-methoxy-1-methylethyl)benzene.

    Abstract translation: 根据一些方面,本公开涉及形成5-叔丁基间苯二甲酸二甲酯的方法,其包括在包含甲醇和脱水剂作为化学试剂的合成方法中将5-叔丁基间苯二甲酸转化为5-叔丁基间苯二甲酸二甲酯。 在其它方面,本公开涉及形成5-叔丁基-1,3-双(1-甲氧基-1-甲基乙基)苯的方法,其包括将5-叔丁基-1,3-双(1- 羟基-1-甲基乙基)苯与Brnnsted-Lowry超级碱基进行甲基化,将去质子化的5-叔丁基-1,3-双(1-羟基-1-甲基乙基)苯甲基化,形成5-叔丁基-1,3 - 双(1-甲氧基-1-甲基乙基)苯。

    MEDICAL DEVICES AND METHODS FOR MONITORING AND TREATMENT WITH SYNTHETIC POLYMERS EXHIBITING SPECIFIC BINDING

    公开(公告)号:US20220125381A1

    公开(公告)日:2022-04-28

    申请号:US17507982

    申请日:2021-10-22

    Abstract: Embodiments herein relate to medical devices and methods for monitoring and/or treatment including the use of synthetic polymers exhibiting specific binding for compounds such as disease state markers or toxic substances. In an embodiment, a method of testing a patient for a disease state is included, the method can include withdrawing a fluid sample from the patient and contacting the fluid sample with an extracorporeal monitoring device. The extracorporeal monitoring device can include a microporous membrane. The microporous membrane can include a synthetic polymer, wherein the synthetic polymer exhibits binding specificity with a disease state marker. The method can further include evaluating the extracorporeal monitoring device for the presence of the disease state marker. Other embodiments are included herein.

Patent Agency Ranking